Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.

Hirono S, Hasegawa Y, Sakaida T, Uchino Y, Hatano K, Iuchi T.

Sci Rep. 2019 Nov 28;9(1):17794. doi: 10.1038/s41598-019-54398-2.

2.

Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.

Tsien CI, Brown D, Normolle D, Schipper M, Piert M, Junck L, Heth J, Gomez-Hassan D, Ten Haken RK, Chenevert T, Cao Y, Lawrence T.

Clin Cancer Res. 2012 Jan 1;18(1):273-9. doi: 10.1158/1078-0432.CCR-11-2073. Epub 2011 Nov 7.

3.

Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma.

Hsieh SY, Chan DT, Kam MK, Loong HH, Tsang WK, Poon DM, Ng SC, Poon WS.

Hong Kong Med J. 2017 Dec;23(6):594-8. doi: 10.12809/hkmj165002. Epub 2017 Aug 11.

4.

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.

Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.

PMID:
16168843
5.

Usefulness of 11C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report.

Nakano T, Tamura K, Tanaka Y, Inaji M, Hayashi S, Kobayashi D, Nariai T, Toyohara J, Ishii K, Maehara T.

Case Rep Oncol. 2018 Jul 3;11(2):442-449. doi: 10.1159/000490457. eCollection 2018 May-Aug.

6.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
7.

Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.

Lee IH, Piert M, Gomez-Hassan D, Junck L, Rogers L, Hayman J, Ten Haken RK, Lawrence TS, Cao Y, Tsien C.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):479-85. doi: 10.1016/j.ijrobp.2008.04.050. Epub 2008 Oct 1.

8.

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.

Brahm CG, den Hollander MW, Enting RH, de Groot JC, Solouki AM, den Dunnen WFA, Heesters MAAM, Wagemakers M, Verheul HMW, de Vries EGE, Pruim J, Walenkamp AME.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2404-2412. doi: 10.1007/s00259-018-4090-4. Epub 2018 Jul 21.

9.

Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.

Lukács G, Tóth Z, Sipos D, Csima M, Hadjiev J, Bajzik G, Cselik Z, Semjén D, Repa I, Kovács Á.

Ideggyogy Sz. 2018 Mar 30;71(3-04):95-103. doi: 10.18071/isz.71.0095.

PMID:
29889468
10.

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Pötzi C, Becherer A, Marosi C, Karanikas G, Szabo M, Dudczak R, Kletter K, Asenbaum S.

J Neurooncol. 2007 Sep;84(3):305-14. Epub 2007 May 11.

PMID:
17492401
11.

MRI and 11C-methyl-L-methionine PET Differentiate Bevacizumab True Responders After Initiating Therapy for Recurrent Glioblastoma.

Beppu T, Terasaki K, Sasaki T, Sato Y, Tomabechi M, Kato K, Sasaki M, Ogasawara K.

Clin Nucl Med. 2016 Nov;41(11):852-857.

PMID:
27648703
12.

Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.

Fukuoka K, Yanagisawa T, Watanabe Y, Suzuki T, Matsutani M, Kuji I, Nishikawa R.

J Neurosurg Pediatr. 2015 Oct;16(4):367-71. doi: 10.3171/2015.3.PEDS14458. Epub 2015 Jul 3.

PMID:
26140394
13.

C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.

Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, Mahmood U.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1024-1028. doi: 10.1016/j.ijrobp.2018.06.011. Epub 2018 Jun 18.

PMID:
29913253
14.

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Blumenthal DT, Gorlia T, Gilbert MR, Kim MM, Burt Nabors L, Mason WP, Hegi ME, Zhang P, Golfinopoulos V, Perry JR, Hyun Nam D, Erridge SC, Corn BW, Mirimanoff RO, Brown PD, Baumert BG, Mehta MP, van den Bent MJ, Reardon DA, Weller M, Stupp R.

Neuro Oncol. 2017 Aug 1;19(8):1119-1126. doi: 10.1093/neuonc/nox025.

15.

The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.

Park CK, Lee SH, Kim TM, Choi SH, Park SH, Heo DS, Kim IH, Jung HW.

J Neurooncol. 2013 Apr;112(2):277-83. doi: 10.1007/s11060-013-1060-3. Epub 2013 Feb 2.

PMID:
23377829
16.

Methionine Uptake and Required Radiation Dose to Control Glioblastoma.

Iuchi T, Hatano K, Uchino Y, Itami M, Hasegawa Y, Kawasaki K, Sakaida T, Hara R.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):133-40. doi: 10.1016/j.ijrobp.2015.04.044. Epub 2015 May 8. Erratum in: Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):215. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):215.

PMID:
26130232
17.

Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Kawai N, Maeda Y, Kudomi N, Miyake K, Okada M, Yamamoto Y, Nishiyama Y, Tamiya T.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):441-50. doi: 10.1007/s00259-010-1645-4. Epub 2010 Nov 12.

PMID:
21072512
18.

Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy.

Kawasaki T, Miwa K, Shinoda J, Asano Y, Takei H, Ikegame Y, Yokoyama K, Yano H, Iwama T.

World Neurosurg. 2019 May;125:93-100. doi: 10.1016/j.wneu.2019.01.129. Epub 2019 Feb 1.

PMID:
30716494
19.

Analysis of progression and recurrence of meningioma using (11)C-methionine PET.

Ikeda H, Tsuyuguchi N, Kunihiro N, Ishibashi K, Goto T, Ohata K.

Ann Nucl Med. 2013 Oct;27(8):772-80. doi: 10.1007/s12149-013-0747-z. Epub 2013 Jun 26.

PMID:
23801406
20.

Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.

Daróczi B, Szántó E, Tóth J, Barzó P, Bognár L, Bakó G, Szántó J, Mózes P, Hideghéty K.

Ideggyogy Sz. 2013 Nov 30;66(11-12):391-8.

PMID:
24555238

Supplemental Content

Support Center